455 related articles for article (PubMed ID: 10224346)
1. Antifungal prophylaxis in neutropenic patients with hematologic malignancies: is there a real benefit?
Böhme A; Karthaus M; Hoelzer D
Chemotherapy; 1999; 45(3):224-32. PubMed ID: 10224346
[TBL] [Abstract][Full Text] [Related]
2. Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies.
Cornely OA; Ullmann AJ; Karthaus M
Blood; 2003 May; 101(9):3365-72. PubMed ID: 12393455
[TBL] [Abstract][Full Text] [Related]
3. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
Glasmacher A; Prentice A; Gorschlüter M; Engelhart S; Hahn C; Djulbegovic B; Schmidt-Wolf IG
J Clin Oncol; 2003 Dec; 21(24):4615-26. PubMed ID: 14673051
[TBL] [Abstract][Full Text] [Related]
4. Antifungal prophylaxis during neutropenia and immunodeficiency.
Lortholary O; Dupont B
Clin Microbiol Rev; 1997 Jul; 10(3):477-504. PubMed ID: 9227863
[TBL] [Abstract][Full Text] [Related]
5. Second- versus first-generation azoles for antifungal prophylaxis in hematology patients: a systematic review and meta-analysis.
Ping B; Zhu Y; Gao Y; Yue C; Wu B
Ann Hematol; 2013 Jun; 92(6):831-9. PubMed ID: 23455400
[TBL] [Abstract][Full Text] [Related]
6. [Antifungal prophylaxis in neutropenic cancer patients and in allogeneic bone marrow transplantation].
Blau IW; Fauser AA
Mycoses; 1996; 39 Suppl 1():81-6. PubMed ID: 8767276
[TBL] [Abstract][Full Text] [Related]
7. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
[TBL] [Abstract][Full Text] [Related]
8. Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review.
Pechlivanoglou P; Le HH; Daenen S; Snowden JA; Postma MJ
J Antimicrob Chemother; 2014 Jan; 69(1):1-11. PubMed ID: 23975736
[TBL] [Abstract][Full Text] [Related]
9. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
[TBL] [Abstract][Full Text] [Related]
10. Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies.
Grigull L; Beilken A; Schmid H; Kirschner P; Sykora KW; Linderkamp C; Donnerstag F; Goudeva L; Heuft HG; Welte K
Support Care Cancer; 2006 Jul; 14(7):783-6. PubMed ID: 16482446
[TBL] [Abstract][Full Text] [Related]
11. Primary antifungal prophylaxis: decrease of invasive fungal disease incidence and reduction of risk factors in haematological patients in a 5-year retrospective study.
Li Y; Liu M; Zhai B; Zhao X; Wang L; Li H; Wang S; Zhu H; Wang Q; Gao C; Huang W; Yu L
Intern Med J; 2018 Jun; 48(6):713-720. PubMed ID: 29230923
[TBL] [Abstract][Full Text] [Related]
12. Advances in antifungal prophylaxis and empiric therapy in patients with hematologic malignancies.
Murali S; Langston A
Transpl Infect Dis; 2009 Dec; 11(6):480-90. PubMed ID: 19725908
[TBL] [Abstract][Full Text] [Related]
13. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
Glasmacher A; Prentice AG
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
[TBL] [Abstract][Full Text] [Related]
14. [Prophylaxis against mycoses in neutropenic patients].
Arning M; Aul C
Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
[TBL] [Abstract][Full Text] [Related]
15. Antifungal prophylaxis in bone marrow transplantation.
Milliken ST; Powles RL
Rev Infect Dis; 1990; 12 Suppl 3():S374-9. PubMed ID: 2184515
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of fungal infections in children and adolescents with cancer].
Groll AH; Ritter J; Müller FM
Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
[TBL] [Abstract][Full Text] [Related]
17. Prevention, diagnosis, and treatment of invasive fungal infections in patients with cancer and neutropenia.
Cumbo TA; Segal BH
J Natl Compr Canc Netw; 2004 Sep; 2(5):455-69. PubMed ID: 19780254
[TBL] [Abstract][Full Text] [Related]
18. [Azole antifungal agents in the prevention of fungal infections in neutropenic patients and bone marrow graft recipients].
Lortholary O; Dupont B
Ann Med Interne (Paris); 1997; 148(3):258-67. PubMed ID: 9255336
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Cornely OA; Böhme A; Buchheidt D; Glasmacher A; Kahl C; Karthaus M; Kern W; Krüger W; Maschmeyer G; Ritter J; Salwender HJ; Sandherr M; Schiel X; Schüttrumpf S; Sieniawski M; Silling G; Ullmann AJ; Wolf HH;
Ann Hematol; 2003 Oct; 82 Suppl 2():S186-200. PubMed ID: 13680164
[TBL] [Abstract][Full Text] [Related]
20. Antifungal prophylaxis in neutropenic patients with hematologic malignancies.
Böhme A; Karthaus M; Hoelzer D
Antibiot Chemother (1971); 2000; 50():69-78. PubMed ID: 10874456
[No Abstract] [Full Text] [Related]
[Next] [New Search]